JP2014516962A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516962A5 JP2014516962A5 JP2014511396A JP2014511396A JP2014516962A5 JP 2014516962 A5 JP2014516962 A5 JP 2014516962A5 JP 2014511396 A JP2014511396 A JP 2014511396A JP 2014511396 A JP2014511396 A JP 2014511396A JP 2014516962 A5 JP2014516962 A5 JP 2014516962A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- volume
- ethanol
- dermatitis
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 32
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 201000004624 Dermatitis Diseases 0.000 claims 8
- 239000004480 active ingredient Substances 0.000 claims 8
- 208000017520 skin disease Diseases 0.000 claims 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- 239000003246 corticosteroid Substances 0.000 claims 4
- 229960003662 desonide Drugs 0.000 claims 4
- WBGKWQHBNHJJPZ-LECWWXJVSA-N desonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O WBGKWQHBNHJJPZ-LECWWXJVSA-N 0.000 claims 4
- 229960002714 fluticasone Drugs 0.000 claims 4
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims 4
- 229960001664 mometasone Drugs 0.000 claims 4
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 4
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 229960002537 betamethasone Drugs 0.000 claims 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 claims 2
- 229960002842 clobetasol Drugs 0.000 claims 2
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 239000000839 emulsion Substances 0.000 claims 2
- 229940043075 fluocinolone Drugs 0.000 claims 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 claims 2
- 229960000890 hydrocortisone Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 238000011200 topical administration Methods 0.000 claims 2
- 229960005294 triamcinolone Drugs 0.000 claims 2
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 206010017543 Fungal skin infection Diseases 0.000 claims 1
- 206010058898 Hand dermatitis Diseases 0.000 claims 1
- 201000009053 Neurodermatitis Diseases 0.000 claims 1
- 206010030012 Occupational dermatitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 241001303601 Rosacea Species 0.000 claims 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 1
- 206010040844 Skin exfoliation Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 claims 1
- 201000004647 tinea pedis Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161486644P | 2011-05-16 | 2011-05-16 | |
| US61/486,644 | 2011-05-16 | ||
| US201261612203P | 2012-03-16 | 2012-03-16 | |
| US61/612,203 | 2012-03-16 | ||
| PCT/US2012/036966 WO2012158405A2 (en) | 2011-05-16 | 2012-05-08 | Compositions and methods for the treatment of skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014516962A JP2014516962A (ja) | 2014-07-17 |
| JP2014516962A5 true JP2014516962A5 (enExample) | 2015-06-25 |
Family
ID=47177559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014511396A Pending JP2014516962A (ja) | 2011-05-16 | 2012-05-08 | 皮膚疾患の処置のための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130123221A1 (enExample) |
| EP (1) | EP2709632A4 (enExample) |
| JP (1) | JP2014516962A (enExample) |
| CA (1) | CA2834710A1 (enExample) |
| WO (1) | WO2012158405A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8580286B2 (en) * | 2012-03-16 | 2013-11-12 | Dale L. Pearlman | Compositions and methods for the treatment of skin diseases |
| US10111956B2 (en) | 2013-06-03 | 2018-10-30 | Tolmar, Inc. | Corticosteroid compositions |
| WO2015127390A1 (en) | 2014-02-21 | 2015-08-27 | Avadim Technologies, Inc. | Method for maintenance of urethral catheters |
| CN104473865A (zh) * | 2014-11-17 | 2015-04-01 | 重庆华邦制药有限公司 | 地奈德凝胶剂及其制备方法 |
| CA2968525A1 (en) * | 2014-11-19 | 2016-05-26 | Avadim Technologies, Inc. | Method for the prevention and treatment of acne |
| EP3982909A4 (en) | 2019-06-12 | 2023-11-29 | Avadim Health, Inc. | COMPOSITIONS AND METHODS FOR ANTISEPTIC TREATMENT OF BIOFILMS ON MAMMALIAN TISSUE |
| CN112263542B (zh) * | 2020-10-19 | 2023-09-01 | 澳美制药厂有限公司 | 地奈德纳米乳凝胶组合物及其制备方法 |
| CN116059157B (zh) * | 2022-12-29 | 2025-02-18 | 江苏知原药业股份有限公司 | 一种地奈德乳膏的制备工艺 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4185100A (en) * | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
| US4147770A (en) * | 1976-12-27 | 1979-04-03 | Scholl, Inc. | Preparation for treating dermatitis in the nature of tinea pedis |
| US4954487A (en) * | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
| US4246261A (en) * | 1979-08-09 | 1981-01-20 | Scott Eugene J Van | Additives enhancing topical corticosteroid action |
| JPS5750914A (en) * | 1980-09-12 | 1982-03-25 | Shionogi & Co Ltd | Betamethasone external pharmaceutical |
| JPS58185514A (ja) * | 1982-04-22 | 1983-10-29 | Hisamitsu Pharmaceut Co Inc | 新規な局所用消炎鎮痛ゲル状クリ−ム剤 |
| US4552872A (en) * | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
| JPS6013711A (ja) * | 1983-06-21 | 1985-01-24 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | コルチコステロイドを含有する浸透局所製薬組成物 |
| MY102980A (en) * | 1986-10-31 | 1993-03-31 | Pfizer | Transdermal flux enhancing compositions |
| EP0325949B1 (en) * | 1988-01-13 | 1991-12-18 | Schwarz Pharma Ag | Concentrated solutions of corticosteroids and method of making them |
| JPH05286860A (ja) * | 1992-04-03 | 1993-11-02 | Kowa Co | ゲル軟膏剤 |
| CA2151774C (en) * | 1994-06-27 | 1999-04-06 | Minh Quang Hoang | Skin disinfecting formulations |
| US5486537A (en) * | 1995-01-20 | 1996-01-23 | Dayton Laboratories, Inc. | Topical anti-fungal composition for skin and keratinous tissue |
| GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
| US6238683B1 (en) * | 1998-12-04 | 2001-05-29 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
| JP3448006B2 (ja) * | 2000-03-29 | 2003-09-16 | 独立行政法人食品総合研究所 | 機能性エマルション |
| CA2505407A1 (en) * | 2002-12-12 | 2004-06-24 | Galderma Research & Development, S.N.C. | Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| FR2850866B1 (fr) * | 2003-02-06 | 2007-04-20 | Seppic Sa | Melange de latex inverse auto-inversible et d'une poudre a usage cosmetique ou pharmaceutique; utilisation comme agent de texture |
| US20050069499A1 (en) * | 2003-09-25 | 2005-03-31 | Moshe Arkin | Foamable compositions, processes of preparing same and uses thereof |
| US20050196450A1 (en) * | 2004-03-04 | 2005-09-08 | Elka Touitou | Method and composition for burned skin |
| CA2601694A1 (en) * | 2005-03-14 | 2006-09-21 | Macrochem Corporation | Enhancement of macrolide penetration through human skin |
| JP5111117B2 (ja) * | 2005-12-22 | 2012-12-26 | 興和株式会社 | ステロイドの経時的安定性が改善された外用製剤 |
| JP2007217394A (ja) * | 2006-02-16 | 2007-08-30 | I-Nage:Kk | 医薬組成物 |
| ES2543209T3 (es) * | 2009-09-24 | 2015-08-17 | Evonik Degussa Gmbh | Polisiloxanos reticulados, proceso para su preparación y uso de los polisiloxanos reticulados en sistemas emulgentes para emulsiones de agua en aceite |
-
2012
- 2012-05-08 EP EP12786665.5A patent/EP2709632A4/en not_active Withdrawn
- 2012-05-08 WO PCT/US2012/036966 patent/WO2012158405A2/en not_active Ceased
- 2012-05-08 CA CA2834710A patent/CA2834710A1/en not_active Abandoned
- 2012-05-08 US US13/466,860 patent/US20130123221A1/en not_active Abandoned
- 2012-05-08 JP JP2014511396A patent/JP2014516962A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516962A5 (enExample) | ||
| JP2015535214A5 (enExample) | ||
| WO2012143576A3 (en) | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) | |
| JP2014505733A5 (enExample) | ||
| CA2822320A1 (en) | Composition for the treatment of skin conditions | |
| NZ703808A (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof | |
| WO2011026076A3 (en) | Topical formulations comprising a steroid | |
| JP2014511393A5 (enExample) | ||
| JP2016527307A5 (enExample) | ||
| US9034351B2 (en) | Compositions and methods for the treatment of skin diseases | |
| BR112014005434A2 (pt) | composições farmacêuticas | |
| WO2012158405A2 (en) | Compositions and methods for the treatment of skin diseases | |
| WO2011147536A3 (en) | Topical pharmaceutical compositions comprising mometasone furoate | |
| MX2014014818A (es) | Composicion farmaceutica para el tratamiento de enfermedades inflamatorias de la piel. | |
| US8936814B2 (en) | Skin cream | |
| CN106170285A (zh) | 包含抗真菌剂和甾类化合物的药物组合物 | |
| WO2015100348A8 (en) | Keloid reduction using topical allantoin | |
| BRPI1002067A8 (pt) | Formulação leishmanicida e seu uso | |
| JP5849550B2 (ja) | ステロイド性抗炎症薬含有外用剤 | |
| CN104771405A (zh) | 一种复方特比萘芬制剂及其应用 | |
| US20180078492A1 (en) | Compositions And Method For Treating Fungal Skin Conditions And Inflammation | |
| FI3482761T3 (fi) | Kromoglisiinihappoa käsittäviä koostumuksia ihottuman hoitoon | |
| CY1116609T1 (el) | Τοπικη συνθεση η οποια περιλαμβανει ενα κορτικοστεροειδες ως δραστικο συστατικο | |
| Platonova et al. | Justification of the composition of combined dermatological ointments | |
| JP5909941B2 (ja) | ステロイド性抗炎症薬含有外用剤 |